We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-11.5%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$123M
AUM Growth
-$22.6M
Cap. Flow
-$737K
Cap. Flow %
-0.6%
Top 10 Hldgs %
74.86%
Holding
66
New
3
Increased
7
Reduced
21
Closed
11

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.54M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$1.52M
3
SVRA icon
Savara
SVRA
+$1.28M
4
CRDF icon
Cardiff Oncology
CRDF
+$1.12M
5
SCYX icon
SCYNEXIS
SCYX
+$496K

Top Sells

Rank Stock Value
1
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$3.58M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$1.28M
3
CZOO
Cazoo Group Ltd
CZOO
+$498K
4
ONCS
OncoSec Medical Incorporated
ONCS
+$449K
5
ISOS.U
Isos Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-third of
ISOS.U
+$245K

Sector Composition

Rank Sector Weight
1 Healthcare 72.57%
2 Financials 6.3%
3 Communication Services 3.87%
4 Technology 2.66%
5 Consumer Discretionary 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRDF icon
1
Cardiff Oncology
CRDF
$59.8M
$16.8M 13.61%
2,522,083
+178,750
+8% +$1.12M
SBBP
2
DELISTED
Strongbridge Biopharma plc.
SBBP
$16.4M 13.27%
8,024,542
-58,900
-0.7% -$137K
MTEM
3
DELISTED
Molecular Templates, Inc.
MTEM
$14.3M 11.63%
142,533
– –
SRRA
4
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$9.71M 7.86%
442,754
-1,205
-0.3% -$24.1K
SVRA icon
5
Savara
SVRA
$1.13B
$9.52M 7.71%
6,896,551
+945,536
+16% +$1.28M
SCYX icon
6
SCYNEXIS
SCYX
$44.5M
$8.29M 6.72%
195,550
+9,472
+5% +$496K
GLD icon
7
SPDR Gold Trust
GLD
$130B
$6.7M 5.43%
40,820
– –
KALA icon
8
KALA BIO
KALA
$15.7M
$4.53M 3.67%
692
+9
+1% +$77.7K
RZLT icon
9
Rezolute
RZLT
$421M
$3.17M 2.57%
424,243
– –
CTIC
10
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$2.95M 2.39%
1,000,000
-1,314,533
-57% -$3.58M
ADXN
11
Addex Therapeutics
ADXN
$7.52M
$2.4M 1.94%
13,297
– –
LUXA
12
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
$1.96M 1.59%
200,000
– –
SPY icon
13
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$1.49M 1.21%
+3,480
New +$1.54M
EFA icon
14
iShares MSCI EAFE ETF
EFA
$76.5B
$1.48M 1.2%
+19,000
New +$1.52M
AAC.U
15
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
$1.38M 1.12%
139,680
– –
INTU icon
16
Intuit
INTU
$80.6B
$1.02M 0.82%
1,884
-1
-0.1% -$539
GOOG icon
17
Alphabet (Google) Class C
GOOG
$4.32T
$992K 0.8%
7,440
– –
EIGR
18
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$939K 0.76%
4,687
+66
+1% +$15.7K
SPGI icon
19
S&P Global
SPGI
$135B
$880K 0.71%
2,072
-1
-0% -$433
CVNA icon
20
Carvana
CVNA
$50.6B
$870K 0.71%
14,430
-10
-0.1% -$665
META icon
21
Meta Platforms (Facebook)
META
$1.69T
$870K 0.71%
2,565
-1
-0% -$360
MSFT icon
22
Microsoft
MSFT
$2.98T
$862K 0.7%
3,057
-2
-0.1% -$582
MCO icon
23
Moody's
MCO
$90.7B
$845K 0.68%
2,380
-2
-0.1% -$754
NFLX icon
24
Netflix
NFLX
$313B
$828K 0.67%
13,570
+380
+3% +$20.9K
CRM icon
25
Salesforce
CRM
$141B
$810K 0.66%
2,986
-2
-0.1% -$508
1
2 3

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q3 2021 Portfolio in Review

As of Q3 2021, Caxton Corporation held 66 positions worth $123M, down 15% from $146M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Caxton Corporation's Q3 2021 filing shows 3 new, 7 increased, 21 reduced and 11 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 3,480 shares worth $1.49M. The largest sale was CTI BioPharma Corp. (DE) Common Stock, an estimated $3.58M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 78% a quarter earlier, followed by Financials and Communication Services.

  • Caxton Corporation's largest Q3 2021 buy was State Street SPDR S&P 500 ETF Trust: 3,480 shares worth $1.49M.
  • Caxton Corporation added most to Savara in Q3 2021, an estimated $1.28M increase.
  • Caxton Corporation's biggest Q3 2021 reduction was CTI BioPharma Corp. (DE) Common Stock, cutting an estimated $3.58M.
  • Caxton Corporation fully exited IVERIC bio, Inc. Common Stock in Q3 2021, selling an estimated $1.28M.
  • Caxton Corporation's ten largest holdings make up 75% of its $123M portfolio in Q3 2021.
  • Caxton Corporation opened 3 new positions and closed 11 in Q3 2021.
  • Caxton Corporation's portfolio value fell 15% quarter-over-quarter to $123M.

Based on Caxton Corporation's 13F filing for Q3 2021, filed 15 Nov 2021.